罕见的乳腺癌审查
1Department of Diagnostic and Interventional Imaging, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
Healthcare (Basel, Switzerland)
|December 17, 2024
概括
本综述分析了罕见的乳腺癌,突出了不同的亚型及其治疗方法. 分子分析和向治疗的进步为这些具有挑战性的恶性瘤提供了更好的结果.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 病理学 病理学 病理学
背景情况:
- 乳腺癌包括罕见的亚型,具有独特的临床挑战.
- 了解流行病学,病理学,预后和治疗对于罕见的乳腺癌至关重要.
研究的目的:
- 提供对罕见乳腺癌的综合分析,包括上皮和非上皮亚型.
- 探索他们治疗方法的最新进展.
主要方法:
- 系统审查最近的文献 (过去五年) 和基础研究.
- 分析分子分析,临床试验,向疗法和免疫疗法.
主要成果:
- 罕见的上皮亚型 (管状,粘膜状,髓状) 通常具有有利的预后.
- 非上皮癌 (肉瘤,淋巴瘤) 由于具有攻击性,需要个性化治疗.
- 针对性疗法 (HER2,PI3K,PARP抑制剂) 和免疫疗法 (PD-1 抑制剂) 对特定亚型具有前景.
结论:
- 由于研究有限,罕见的乳腺癌亚型存在管理挑战.
- 分子分析和下一代测序是个性化治疗的关键.
- 未来的研究应该优先考虑临床试验和合作努力,以改善结果.
更多相关视频
相关概念视频
Cancer-Critical Genes I: Proto-oncogenes
8.7K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328


